Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis
Status:
Recruiting
Trial end date:
2026-05-20
Target enrollment:
Participant gender:
Summary
This study aims to compare the efficacy and safety of the edoxaban and the warfarin in atrial
fibrillation patients with mitral stenosis.
The study design is a multicenter, randomized, open-label, investigator initiated phase 2
trial. The patients were randomly assigned to Edoxaban or Warfarin groups. Primary outcome
was a composite of stroke and systemic arterial thromboembolism. The safety outcome was major
bleeding.